Home / Resources / Q4 2024 Gene, Cell, + RNA Therapy Landscape Report
Q4 2024 Gene, Cell, + RNA Therapy Landscape Report

This report, by Citeline and the American Society of Gene & Cell Therapy (ASGCT), suggests we're entering a new phase in the evolution of molecular medicine.

Discover more by downloading the report.

''
Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Thank you.




Your download should open in a new window. You can also manually download by clicking the button below.
Related products
Healthcare professional monitoring and analyzing R and D trends.
Pharmaprojects
The industry standard for tracking and analyzing the global drug R&D landscape
Expert analyst presenting data insights on a projected screen.
Biomedtracker
Real-time tracking and analysis of the drug development pipeline
Professional using a laptop device to access Trialtrove for trial insights and strategy.
Trialtrove
The go-to resource for informing clinical trial strategy, design and execution

Related resources

Cell and Gene Therapy Regulatory Report H1 2024
OCT 11, 2024
Report
Clinical

ISCT Cell and Gene Therapy Global Regulatory Report H1 2024

The Cell and Gene Therapy Global Regulatory Report from ISCT and Citeline provides a global overview of the cell and gene therapy regulatory landscape.

CGT Development Is Booming_resource-card-thumbnail
NOV 22, 2023
Article
Commercial

CGT Development Is Booming, but Manufacturing Workforce Must Keep Up

Due to unprecedented growth in the development of cell and gene therapies, there is high demand for certain workforce roles.

Report cover for the Q3 2024 Gene, Cell, & RNA Therapy Landscape Report
OCT 23, 2024
Report
Commercial

Q3 2024 Gene, Cell, + RNA Therapy Landscape Report

In this report, by Citeline and the American Society of Gene & Cell Therapy (ASGCT), new approvals in Q3 2024 were focused on the RNA landscape.

View all